MLL-r Leukemia

Mixed lineage leukemia-1 (MLL-1) is a particular type of acute leukemia from the mutation of the MLL/KMT2A gene. This mutation can be seen in pediatrics, adults and therapy-induced acute leukemia’s. Discover the latest research on MLL-r leukemia here.

October 17, 2021

Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia.

Critical Reviews in Oncology/hematology
Lilly VelentzaLars Sävendahl
October 16, 2021

Chemotherapy is a risk factor for caries and gingivitis in children with acute lymphoblastic leukemia. A retrospective cohort study.

International Journal of Paediatric Dentistry
Anis ShayaniCesar Rivera-Martínez
October 15, 2021
Open Access

Clustered PHD domains in mixed lineage leukaemia proteins are attracted by acetylation-rich active promoters and enhancers

BioRxiv : the Preprint Server for Biology
A. M. Stroynowska-CzerwinskaMatthias Bochtler
October 15, 2021

Childhood cancer and residential proximity to petrol stations: a nationwide registry-based case-control study in Switzerland and an updated meta-analysis.

International Archives of Occupational and Environmental Health
Antonella MazzeiBen D Spycher
October 15, 2021

[Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
M X ZhangB Jiang
October 15, 2021

Integrated ecological risk assessment of heavy metals in an oil shale mining area after restoration.

Journal of Environmental Management
Tengfei MaGuining Lu
October 15, 2021

Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia.

Pediatric Blood & Cancer
Annelien L van BinsbergenRob Pieters
October 15, 2021

Parents Caring for Children Diagnosed with a Blood Cancer from Infancy to Emerging Adulthood: A Life span Perspective.

Journal of Adolescent and Young Adult Oncology
Amanda L KastrinosCarla L Fisher
October 14, 2021

An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.

Journal of Experimental & Clinical Cancer Research : CR
Rui WangYamei Pang
October 14, 2021

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.

Eric J ChowSteven E Lipshultz
October 13, 2021
Case Report

Lineage switch from acute myeloid leukemia with KMT2A-PTD to mixed phenotype acute leukemia with t(v;11q23).

International Journal of Laboratory Hematology
Ting LiHui Wang
October 13, 2021
Open Access

ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.

International Journal of Molecular Sciences
Emanuela ChiarellaMaria Mesuraca
October 13, 2021
Open Access

Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.

International Journal of Molecular Sciences
Jochen GreinerBarbara-Ann Guinn
October 13, 2021
Open Access

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.

International Journal of Molecular Sciences
Paul LeeHarinder Gill
October 13, 2021
Open Access

The Microbiome in Childhood Acute Lymphoblastic Leukemia.

Marina OldenburgKatharina L Gössling

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

© 2021 Meta ULC. All rights reserved